Tongmai Yangxin pill reduces myocardial No-reflow via endothelium-dependent NO-cGMP signaling by activation of the cAMP/PKA pathway
Rui Chen, Ting Chen, Tianqi Wang, Xiangdong Dai, Shuying Zhang, Di Jiang, Ke Meng, Yanyan Wang, Tong Geng, Jinpeng Xu, Kun Zhou, Yì Wáng
Topics & Concepts
MedicineMyocardial infarctionNitric oxideInternal medicineCardiologyPharmacologyNitric Oxide and Endothelin EffectsCardiac Fibrosis and RemodelingPhosphodiesterase function and regulation